SavedAdd your journal

Journals / Annals of Medical Research / 2019 / Cilt: 26 - Sayı: 4

Determinants of survival in gastric cancer: A single center experience

Mürşit DİNÇER
Koray KARABULUT
Fadlı DOĞAN
Pages
596–601
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A higher T stage was associated with shorter survival (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Gastric cancer is the second leading cause of cancer deaths worldwide.
📊
Key Findings & Data:Result of preoperative diagnostic work up, operative data, histopathology of the surgical specimen, and postoperative follow up parameters were evaluated and recorded.Results: Among a total of 139 patients operated due to gastric malignancy between January 2008 and January 2014 in our unit, 124 were diagnosed with an adenocarcinoma.
💡
Conclusion & Impact:A higher T stage was associated with shorter survival (p
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Gastric cancer is the second leading cause of cancer deaths worldwide. The effect of lymph node dissection and the extent of gastric resection on survival remains controversial, while improved survival has been reported with combined chemotherapy and radiotherapy. In this study, we aimed to present a single center experience.Material and Methods: Patients undergoing gastric resection due to gastric cancer were retrospectively assessed in order to examine the determinants of survival in gastric adenocarcinoma. Gastric malignancies other than adenocarcinoma were excluded from the study. Result of preoperative diagnostic work up, operative data, histopathology of the surgical specimen, and postoperative follow up parameters were evaluated and recorded.Results: Among a total of 139 patients operated due to gastric malignancy between January 2008 and January 2014 in our unit, 124 were diagnosed with an adenocarcinoma. The median duration of follow up was 6 months, during which 53 patients (42.7%) were found to have disease recurrence (10 local, and 43 systemic). A higher T stage was associated with shorter survival (p

🔖

Cite This Article

DİNÇER, M., KARABULUT, K., DOĞAN, F. (2022). Determinants of survival in gastric cancer: A single center experience. Annals of Medical Research, Cilt: 26 - Sayı: 4, 596–601. https://ajindex.com/articles/446982

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61: 69-90
  2. Santoro R, Carboni F, Lepiane P, et al. Clinicopathological features and prognosis of gastric cancer in young European adults. Br J Surg 2007;94:737-42
  3. Sano T, Katai H, Sasako M, The management of early gastric cancer. Surg Oncol 2000;1:17-22
  4. Sano T, Katai H, Sasako M, et al. One thousand consecutive gastrectomies without operative mortality. Br J Surg 2002;89:122-123
  5. Ajani JA, Baker J, Pisters PW, et al. Irinotecan plus cisplatin in advanced gastric or gastroesophageal junction carcinoma. Oncology 2001;15:52-4
  6. Gunderson LL. Gastric cancer--patterns of relapse after surgical resection. Semin Radiat Oncol 2002;12:150-61
  7. Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010;11:439-49
  8. Zhang M, Li Z, Zhao B, et al. Predictors of long-term survival in large gastric carcinoma patients. Hepatogastroenterology 2011;58:2162-5
  9. Saka M, Katai H, Fukagawa T, et al. Recurrence in early gastric cancer with lymph node metastasis. Gastric Cancer 2008;11:214-8
  10. Roviello F, Rossi S, Marrelli D, et al. Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol 2006;94:275-80
  11. Greene FL, Page AL, Fleming ID, et al. American Joint Committee on Cancer: AJCC Cancer Staging Manual. 6th ed. New York: Springer, 2002:99-106
  12. Kim JP. Surgical results in gastric cancer. Semin Surg Oncol 1999;17:132-8
  13. Ding YB, Chen GY, Xia JG, et al. Correlation of tumor-positive ratio and number of perigastric lymph nodes with prognosis of gastric carcinoma in surgically treated patients.Word J Gastroenterol 2004;10:182-5
  14. Marrelli D, Roviello F, de Manzoni G, et al. Different patterns of recurrence in gastric cancer depending on Lauren’s histological type: longitudinal study. World J Surg 2002;26:1160-5
  15. Talamanti MS, Kim SP, Yao KA; et al. Surgical outcomes of patients with gastric carcinoma:the importance of primary tumor location and microvessel invasion. Surgery 2003;134:720-7
  16. Mohri Y, Tanaka K, Ohi M, et al. Prognostic significance of host- and tumor-related factors in patients with gastric cancer. World J Surg 2010;34:285-90
  17. Li C, Oh SJ, Kim S, et al. Risk factors of survival and surgical treatment for advanced gastric cancer with large tumor size. J